consists radioactive substance complexed chelating agent dota turn attached vitamin biotin via chemical linker used experimentally pretargeted radioimmunotherapy animal studies well clinical studies pretargeted radioimmunotherapy two three medications applied succession first antibodydrug conjugate administered consists monoclonal antibody designed target tumour chemical marker case dotabiotin therapy one proteins avidin streptavidin time typically one two days let antibody accumulate tumour clearing agent may given eliminate residues antibody still circulating bloodstream especially done humans waiting time radiotherapy administered due high affinity biotin avidin streptavidin radiotherapy accumulates antibody namely tumour delivers antineoplastic immunomodulatory drug article stub help wikipedia expanding nuclear medicine article stub help wikipedia expanding